Top Stories
New Malaria Drug Candidate Exceeds Cure Rate for Standard ACTs in Phase 3 Trial  
Malaria & Neglected Diseases
The 97% cure rate for the novel compound, ganaplacide/lumefantrine in a recent Phase 3 trial offers hope for continued progress rolling ...
Aid Cuts Jeopardise 2024’s Slight Global Progress Against Tuberculosis
Tuberculosis
Last year, the global battle to reduce tuberculosis infections and deaths showed small signs of recovery following three disruptive COVID-19 years ...
Building Africa’s Health Sovereignty: From Dependence to Partnership
Inside View
In August, African leaders gathered in Accra, Ghana, to chart a path for the continent’s future in public health. Their message ...
Dental Amalgam Set to Be Phased out by 2034 to Reduce Toxic Mercury Exposures
Health & Environment
Mercury-containing dental amalgam, used to fill cavities, is set to be phased out globally by 2034 to reduce human exposure to ...
Read more
From Texas to the G20: The Man Leading the World’s Brain Health Movement
Non-Communicable Diseases
News in Brief
Canada Loses Measles Elimination Status
Canada has lost its measles elimination status after 12 months of continuous transmission of the highly infectious disease, the Pan-American ...
10/11/2025
Ghanaian Newborns First to Get New Malaria Medication
Ghana is the first country in the world to roll out a malaria treatment specially formulated for newborn babies. The ...
07/10/2025
Mali Enrols First Pregnant Patient in Malaria Trial
The first pregnant woman infected with malaria has been recruited into a Phase 3 trial in Mali that is evaluating ...
06/10/2025
From Texas to the G20: The Man Leading the World’s Brain Health Movement
Non-Communicable Diseases
More
Global Health Policy in Geneva & Worldwide
africa emediterranean-1 emediterranean-2 europe latam namerica seasia-1 seasia-2 wpacific
Africa
Eastern Mediterranean
Europe
Latin America & Caribbean
North America
South-East Asia
Western Pacific
AfricaMore
New Malaria Drug Candidate Exceeds Cure Rate for Standard ACTs in Phase 3 Trial  
Malaria & Neglected Diseases
Building Africa’s Health Sovereignty: From Dependence to Partnership
Inside View
EXCLUSIVE: US Blocking Consensus on G20 Health Ministers’ Statement 
Health & Environment
From Texas to the G20: The Man Leading the World’s Brain Health Movement
Non-Communicable Diseases
More
Global Health Policy in Geneva & Worldwide
africa emediterranean-1 emediterranean-2 europe latam namerica seasia-1 seasia-2 wpacific
Africa
Eastern Mediterranean
Europe
Latin America & Caribbean
North America
South-East Asia
Western Pacific
AfricaMore
New Malaria Drug Candidate Exceeds Cure Rate for Standard ACTs in Phase 3 Trial  
Malaria & Neglected Diseases
Building Africa’s Health Sovereignty: From Dependence to Partnership
Inside View
EXCLUSIVE: US Blocking Consensus on G20 Health Ministers’ Statement 
Health & Environment
From Texas to the G20: The Man Leading the World’s Brain Health Movement
Non-Communicable Diseases
More
Supported Series